Skip to content
Lower risk Drug recall · FDA · Published March 17, 2025

Biocon Pharma Atorvastatin 40mg Tablets Recall: Failed Dissolution Specifications

Biocon Pharma recalls 40mg Atorvastatin Calcium Tablets due to failed dissolution specifications. This may affect medication effectiveness. Contact for details.

🇺🇸 FDA recall #D-0306-2025DrugBiocon Pharma ›
Take action

Contact the company

Recalling firmBIOCON PHARMA INC485 HWY 1 (S) · ISELIN, NJ 08830
✎ GovInfoNow plain-language explainer

Biocon Pharma is recalling 1000-count bottles of 40mg Atorvastatin Calcium Tablets because they didn't dissolve properly as required. This could mean the medication isn't working correctly for people taking it. Read more at govinfonow.com/recall/32180-biocon-pharma-atorvastatin-40mg-tablets-recall-failed-dissolution-specifications.

Source Summary by GovInfoNow · govinfonow.com/recall/32180-biocon-pharma-atorvastatin-40mg-tablets-recall-failed-dissolution-specifications · Updated August 17, 2026 · FDA enforcement record: FDA #D-0306-2025

Cite this page

“Biocon Pharma Atorvastatin 40mg Tablets Recall: Failed Dissolution Specifications.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32180-biocon-pharma-atorvastatin-40mg-tablets-recall-failed-dissolution-specifications. Based on FDA recall #D-0306-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0306-2025%22&limit=1).

The FDA announced on March 17, 2025, that Biocon Pharma Inc. is recalling Atorvastatin Calcium Tablets USP 40 mg due to failed dissolution specifications. The Class II recall affects 2,184 bottles distributed nationwide.

How to tell if you have it

  • Brand: Biocon Pharma
  • Product: Atorvastatin Calcium Tablets USP 40 mg, 1000-count bottle
  • NDC: 70377-079-13
  • Lot code: AVC24035
  • Expiration date: 03/31/26

The hazard

The tablets have failed dissolution specifications, resulting in lower than required dissolution levels. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Biocon Pharma Inc. has one other recall on record since January 31, 2023, involving Posaconazole Tablets due to high impurities risk. Other recent recalls of similar products include AvKARE Rosuvastatin Tablets 10mg Recall (December 31, 2025), Teva Metoprolol Succinate Tablets Recall (January 29, 2026), and Mylan Acamprosate Tablets Recall (July 24, 2026).

How to tell if you have this one

Check for the 1000-count bottle labeled 'Atorvastatin Calcium Tablets USP 40 mg, Rx Only'. The NDC code is 70377-079-13 and it was manufactured in India with lot number AVC24035.

  • Brand
    Biocon Pharma
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Medication Details

    Look for the NDC code 70377-079-13 on the bottle label to confirm if it's recalled.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “U.S.A. nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 23 days after the firm started it.

1. Firm started the recall: Mar 17, 202512. FDA classified it Class II: Mar 28, 202523. Published in FDA’s Enforcement Report: Apr 9, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What should I do if I have this medication?

The recall does not include a specific remedy, so contact Biocon Pharma for further instructions.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0306-2025 (March 17, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0306-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA